Expression analysis of four long noncoding RNAs in breast cancer

Tumor Biology

Volumn 37, Issue 3, 2016, Pages 2933-2940

  Iranpour, Mostafa ^a   Soudyab, Mohammad ^a   Geranpayeh, Lobat ^b   Mirfakhraie, Reza ^a   Azargashb, Eznollah ^a   Movafagh, Abolfazl ^a   Ghafouri Fard, Soudeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ANRASSF1; ANRIL; Breast cancer; Long noncoding RNA; PTPRG AS1; SOX2OT

Indexed keywords

LONG UNTRANSLATED RNA; ANRIL LONG NON-CODING RNA, HUMAN; ESTROGEN RECEPTOR; LONG NON-CODING RNA SOX2OT, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RNA ANALYSIS; TUMOR VOLUME; UPREGULATION; AGED; BREAST NEOPLASMS; CHEMISTRY; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RNA, LONG NONCODING;

EID: 84944704214     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4135-2     Document Type: Article

References (18)

1. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70. doi:10.1038/nature11412.
2. Mobasheri MB, Shirkoohi R, Zendehdel K, Jahanzad I, Talebi S, Afsharpad M, et al. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines. Tumour Biol. 2015. doi:10.1007/s13277-015-3546-4.
3. Meng J, Li P, Zhang Q, Yang Z, Fu S. A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res. 2014;33(1):84. doi:10.1186/s13046-014-0084-7.
4. Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014;5:e1008. doi:10.1038/cddis.2013.541.
5. Zhao W, Luo J, Jiao S. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep. 2014;4:6591. doi:10.1038/srep06591.
6. Shahryari A, Jazi MS, Samaei NM, Mowla SJ. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet. 2015;6:196. doi:10.3389/fgene.2015.00196.
7. Askarian-Amiri ME, Seyfoddin V, Smart CE, Wang J, Kim JE, Hansji H, et al. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer. PLoS One. 2014;9(7):e102140. doi:10.1371/journal.pone.0102140.
8. Beckedorff FC, Ayupe AC, Crocci-Souza R, Amaral MS, Nakaya HI, Soltys DT, et al. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 2013;9(8):e1003705. doi:10.1371/journal.pgen.1003705.
9. Congrains A, Kamide K, Ohishi M, Rakugi H. ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci. 2013;14(1):1278–92. doi:10.3390/ijms14011278.
10. Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25(5):1086–95. doi:10.1016/j.cellsig.2013.02.006.
11. Seifi-Alan M, Shamsi R, Ghafouri-Fard S, Mirfakhraie R, Zare-Abdollahi D, Movafagh A, et al. Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines. Asian Pac J Cancer Prev. 2014;14(11):6625–9.
12. Dianatpour M, Mehdipour P, Nayernia K, Mobasheri MB, Ghafouri-Fard S, Savad S, et al. Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer. Iran Red Crescent Med J. 2012;14(11):722–6. doi:10.5812/ircmj.3611.
13. Kazemi-Oula G, Ghafouri-Fard S, Mobasheri MB, Geranpayeh L, Mohammad Hossein Modarressi. Upregulation of RHOXF2 and odf4 expression in breast cancer tissues. Cell J (Yakhteh). 2015.
14. Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, et al. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res. 2006;8(5):R58. doi:10.1186/bcr1608.
15. Casbas-Hernandez P, Sun X, Roman-Perez E, D’Arcy M, Sandhu R, Hishida A, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev. 2015;24(2):406–14. doi:10.1158/1055-9965.epi-14-0934.
16. Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, et al. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells. 2014;32(1):126–34. doi:10.1002/stem.1542.
17. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25(2):444–8. doi:10.1096/fj.10-172452.
18. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, et al. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009;33(5):759–67. doi:10.1097/PAS.0b013e31819437f9.